An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer

Name: An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer
Published: 2026
License: Public Domain

Jiangsu Hansoh Pharmaceutical Co., Ltd. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

hs nsclc

nsclc, phase i, drug interaction, hs-10504, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer

Related documents